InvestorsHub Logo
Followers 4
Posts 1391
Boards Moderated 0
Alias Born 03/04/2024

Re: CaptainObvious post# 690358

Friday, 05/10/2024 2:25:01 PM

Friday, May 10, 2024 2:25:01 PM

Post# of 711645
Yes but does not NWBO just have the leasing rights of DCVAX-l as a stand-alone treatment only.

Why would any combo-iteration equate to any added value to NWBO’s SP ?

UCL sure as hell aren’t going to share the research limelight or any future income with Northwest Therapeutics, are they. And why would they ?

Advent may pick up some third party manufacturing work from UCL for the European markets down the line, but again, NWBO is out of the income loop, in this aspect also,isn’t it ?

If I’m wrong, I’m happy to be corrected
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News